The aim of the study was to evaluate the experience of the centre in carrying out and assessing the use of sentinel node biopsy in skin melanoma. Material and methods. From 2000 to 2004, a sentinel node biopsy was carried out on 227 patients being treated for skin melanoma. In all the patients, the sentinel node was subjected to a standard histological evaluation with the application of H+E staining. If no melanoma cells were visualised within the sentinel node, the material was subjected to an immunohistochemical investigation. The patients whose sentinel node included metastases found in the H+E examination or micrometastases identified by means of the immunohistochemical investigation were subjected to a supplementary lymphadenectomy. Results. The sentinel node was identified in all the patients. In a group of 28 patients (12.3%), the presence of metastases within the sentinel node was visualised by means of H+E examination. A group of 199 patients (87.66%) with a metastases-negative sentinel node (H+E staining) was subjected to immunohistochemical evaluation, which revealed the presence of micrometastases in 45 patients (19.82%). Supplementary lymphadenectomy was carried out in patients who screened positive, and metastases were identified in other regional lymph nodes in 11 (4.8%) patients. Conclusions. 1. After finishing the learning curve, the sentinel node biopsy is a simple and effective method, enabling precise assessment of the lymphatic system in patients with skin melanoma. 2. The application of immunohistochemical investigation enabled the identification of micrometastases in 19.8% of the patients, where these were not found in the H+E examination. 3. The application of sentinel node biopsy allowed lymphadenectomy to be avoided in 154 (67.8%) patients.
The frequency of cases of skin melanoma is constantly growing. Increasing exposure to sunshine (holiday trips) and many other factors have doubled the percentage of cases every 10 years in all regions of the world (1) . In Poland in 2002, the incidence indexes were 4.4 and 5.1 out of 100,000 for men and women, respectively (2) . Due to the growing incidence of skin melanoma, it is necessary to constantly broaden the knowledge of this neoplasm. Apart from the surgical treatment, there has so far been no satisfying and effective supplementary therapy (1) .
The most important prognostic factor in patients with skin melanoma is the state of regional lymph nodes (3, 4) . Today, it is known that the elective resection of a regional lymph node where no metastases are diagnosed does not bring a therapeutic profit but that it is, in fact, the cause of numerous complications (massive swellings, paraesthesias, weakening of limb efficiency). Until recently, such a procedure was routine in skin melanoma, although metastases were diagnosed in only 10-20% of cases. It remains important, however, to identify patients with metastatic lesions in the lymph nodes. Besides the prognostic importance in the case of metastases into the lymph nodes, carrying out lymphadenectomy provides prophylaxis against ulceration and compli- cations related with the progression of the disease (lymph node packages, disintegrating lymph nodes). In view of the information presented above, there is a need for precise specification of the state of the lymphatic system by means of the least invasive method possible.
The sentinel node (SN) is the first lymph node on the way of the lymph flowing out of the tumour, and its histopathological image precisely reflects the state of the regional lymphatic system. The sentinel node biopsy (SNB) allows complications related with extensive lymphadenectomy to be avoided, and it enables more precise histopathological assessment of the lymph nodes. In a situation where we have to deal with several lymph nodes, the application of additional staining methods (immunohistochemistry) or even molecular biology techniques becomes necessary for detection of micrometastases or isolated neoplastic cells. If the SN is positive, metastases in the other regional lymph nodes can be identified in about 10-20% of patients (5) . Thus, metastases into regional lymph nodes can be expected only in about 4% of all patients with melanoma of medium thickness. Many studies indicate a clear correlation between patients' survival rate and the state of the SN. The presence of melanoma cells found within the SN reduces the percentage of patient three-year survival rate from 88.5% to 55.8% (6) .
The aim of the study was to evaluate the experience of the centre in carrying out and assessing the use of the sentinel node biopsy in skin melanoma.
MATERIAL AND METHODS
In 2000-2004, the sentinel node biopsy was carried out in 227 patients treated for skin melanoma in the 1 st Department of Oncological and General Surgery, Wielkopolska Cancer Centre. Since 2000, the SNB method has been a standard procedure in the diagnostics of the lymphatic system in patients with skin melanoma. In 1998-1999, the method was applied as part of the learning curve, so each patient was consecutively subjected to elective lymphadenectomy. According to Breslow, the average thickness of infiltration in the studied period was as much as 3.29 mm. Table 1 shows the characteristics of the group of patients. The SN identification was carried out by means of two methods: isotope and staining. All patients in whom the lymph nodes were not clinically noticeable after resection of the primary focus of skin melanoma (according to Breslow, over 0.75 mm) and who did not display the qualities of the generalised neoplastic process were qualified for the SNB. The biopsy was carried out about two weeks after the primary resection of the melanoma. After successful identification and resection in all patients, the sentinel node was subjected to a standard histological assessment, which consisted of a bisection of the node and then staining of the obtained specimens with haematoxylin and eosin. If no melanoma cells were visualised within the sentinel node in the abovementioned examination, the material was subjected to an immunohistochemical investigation (monoclonal antibodies HMB45, MelanA and a polyclonal antibody anti-S100). The patients whose sentinel node included metastases found in the H+E examination or micrometastases identified by means of the immunohistochemical investigation were subjected to supplementary lymphadenectomy.
RESULTS
The sentinel node was identified in all the 227 patients, on average 1.59 nodes were found (minimum -1, maximum -6). In a group 1 ). In 3 patients (1.32%), who had a positive sentinel node in the H+E examination, there were metastases found within another group of lymph nodes during observation (tab. 2). In 6 cases (2.64%) where the immunohistochemical investigation did not reveal the presence of melanoma cells in the sentinel node, metastases within the same regional lymphatic system appeared within an average of 18 months (6-30) (tab. 3). According to the literature, this group should be treated as a falsely negative result for the SNB method.
In two patients, there was an infection of the post-operative wound after the SNB; except for these cases, no complications were observed.
DISCUSSION
The sentinel node biopsy has become a widely accepted procedure in patients with skin melanoma. It is a simple and effective method, enabling assessment of the regional lymphatic system and selection of patients with melanoma metastases into the lymphatic system. A vast majority of centres dealing with the sentinel node biopsy in skin melanoma uses two methods of screening: staining and radio-isotope, which allow a high percentage of identification. In our material, the sentinel node was successfully identified in all cases, and a similar situation is described in many of the current publications (7, 8) . Estourgie et al. presented a group of 250 patients, to whom both of the methods were applied, and the sentinel node was successfully identified in all the cases. An average of 2.3 nodes (1-8) were found, whereas, in our material, this number was 1.59 (1-6) nodes (7) . The experience of the team carrying out a biopsy is decisive in the effectiveness and success of finding the SN. It is recommended that, before beginning with the SNB Fig. 1 (9) . In a study published by Vidal-Sicart et al. concerning the analysis of errors made during the SNB, the first 50 cases were recognised as the learning curve. The author presents three possible errors during the identification of the sentinel node: 1) the surgeon's lack of skills in correctly identifying the sentinel node, 2) the presence of additional route of lymph flow, or 3) a falsely negative histopathological investigation (10). To eliminate the last it is necessary to carry out the histopathological investigation of the sentinel node appropriately and precisely. The standard procedure, which consists of a bisection of the sentinel node and staining of the obtained specimens by means of haematoxylin and eosin, is not sufficient. If we assume that the average size of a lymph node is about 1 cm and that the diameter of a focus of neoplastic cells is about 15 µm, and if we carry out only one section of the node (one specimen), the likelihood of finding these cells is 0.3-0.4% (11) . In a situation when the sentinel node does not contain melanoma cells in an H+E examination, it is necessary to apply additional immunohistochemical staining by means of antibodies directed against protein antigens, usually HMB45, MelanA, and S-100. The application of the abovementioned procedure allows identification of a larger group of patients with metastases within the lymphatic system. As Spanknebel et al. reports, if an extended panel of histopathological examinations is not applied, as many as 12% of positive sentinel nodes may be described as negative (12) . The analysis of our material shows that the application of additional staining where the H+E examination did not reveal the presence of melanoma cells within the sentinel node, allowing the identification of micrometastases in as many as 45 patients (19.8%). Similar results are presented in numerous publications, wherein the percentage of patients in whom immunohistochemistry enabled the location of micrometastases is 7-17.5% (12, 13, 14) . The application of progressively more accurate methods of histopathological assessment enables detection of progressively smaller cellular deposits. If the diameter of melanoma cells within a lymph node is less than 2 mm, they are treated as a micrometastasis, and, if the diameter is under 0.2 mm, they are treated as isolated tumour cells (ITC), where the importance of such cellular deposits remains unclear. The studies by Van Akkooi and Govindarajan suggest that patients who have only isolated tumour cells within the sentinel node should be treated as patients with a negative SN. These studies are based, however, on a small group of patients -under 20 people -with an average observation period of three years (15, 16 ). An analysis published by Scheri et al., where only isolated tumour cells within the sentinel node were found in 57 out of 1328 patients, shows that metastases into the regional non-sentinel lymph nodes were found in 12% of the group. In comparison with the patients with negative sentinel nodes, this group also ran a higher risk of relapse and death due to recrudescence of melanoma (17) . One of the principal purposes of the SNB is to avoid extensive mutilating lymphadenectomy, which was the case for 154 patients (67.8%) in our centre within four years. Supplementary lymphadenectomy is carried out only in patients with identified metastases or micrometastases within the sentinel node. Morton et al. published a study on the comparison of two methods of treatment: SNB vs observation. Immediate lymphadenectomy in the first group of patients prolonged the period free from the disease and minimised the consequences of relapse. Leaving the lymph nodes for observation in the other group of patients (without carrying out lymphadenectomy) caused the development of micrometastases that are frequently found there, consequently resulting in dissemination of the disease into the other lymph nodes and in a shortened period free from relapse. In the group subjected to observation after lymphadenectomy due to the relapse, there were an average of 3.3 nodes with metastases found. In the other group, where the sentinel node turned out to be positive and immediate lymphadenectomy was carried out, 1.4 nodes were found, representing a statistically significant difference (p<0.001). Also the five-year survival rate improved in the group of patients undergoing immediate lymphadenectomy to 72.3% in comparison with 52.4% when the lymph nodes were only left for observation (18) . The authors of this publication proved that carrying out lymphadenectomy in the period when we have to deal only with subclinical metastases into the sentinel node has more clinical importance than a delayed resection of the lymph nodes, which is more likely to result in a relapse. The importance of resection of the regional lymphatic system in the case of a positive sentinel node continues, however, to arouse numerous controversies. Wong et al. published an analysis of 134 patients with skin melanoma who had a positive sentinel node but were not subjected to supplementary lymphadenectomy for various reasons. In this group of patients, the relapse within the lymphatic system applied to 15% of the patients, and the three-year free-fromdisease survival rate was 80% (19) . These results are comparable with the group of patients who had a positive sentinel node but who underwent supplementary lymphadenectomy. It is necessary to continue the search for prognostic factors (the expression of certain genes), which will enable definitive identification of the group of patients requiring supplementary lymphadenectomy.
Relapses occurring within the lymphatic system, in a situation of the negative sentinel node in all examinations, are an important element of evaluation of the applied technique. These cases can be treated as falsely negative sentinel nodes. In the available literature, this percentage applies to about 1.7-18.4% of patients, and the percentage in our analysis was 2.5% (6 patients) of the cases (7, 20) . On the basis of an analysis of 34 cases of falsely negative sentinel nodes, Caraco et al. observed that, in their material, the falsely negative sentinel node most frequently occurred within the neck (37.5%, 3 out of 8 cases of this location) and armpit (19.4%, 19 out of 98). The authors give several possible reasons for the falsely negative sentinel node: 1) a very slow movement of isolated tumour cells in the lymphatic system, which do not manage to reach the sentinel node before the biopsy; 2) the invasion of the whole sentinel node by neoplastic cells, which, at that particular moment, eliminated it from the regular lymph flow such that a wrong node was collected during the biopsy; or 3) technical errors in the procedure; e.g., in the authors' material, no hand-held gamma camera was used intra-operatively during the identification in 45.1% of the cases of a falsely negative sentinel node (20).
Relapses of melanoma beyond the lymphatic system and the occurrence of distant metastases also apply to patients with a negative sentinel node. The occurrence of relapse is influenced by, according to Breslow: the location of the primary lesion, histological type, the pre-
